Newsfeeds Archive - Page 3739 of 19074

2 minute read

BriaCell Reports 71% Central Nervous System Response Rate In Advanced Breast Cancer Patients With Central Nervous System Metastases Support Clinical Efficacy Of Bria-IMT, Alone And In Combination With An Immune Checkpoint Inhibitor

December 28, 9:58 AM

71% intracranial objective response rate (iORR) in BriaCell patients with Central Nervous System (CNS) metastases support clinical efficacy of Bria-IMT™, alone and in combination with an immune checkpoint

BCTX

2 minute read

Silvercorp Revises Bid, Offers $188M For Gold Explorer OreCorp

By Stjepan Kalinic

December 28, 9:57 AM

Canada-based Silvercorp Metals has announced a revised takeover bid for Australian gold developer OreCorp Limited, valued at $188 million.

SVM

1 minute read

Crypto-Related Stocks Are Moving Lower Thursday: What’s Going On?

By Adam Eckert

December 28, 9:53 AM

Several crypto-related stocks including Coinbase Global Inc (NASDAQ: COIN), Marathon Digital Holdings Inc (NASDAQ: MARA) and Riot Platforms Inc (NASDAQ:

BTC

1 minute read

What’s Going On With Alibaba Stock Thursday?

By Anusuya Lahiri

December 28, 9:50 AM

Alibaba Group Holding Limited (NYSE: BABA) stock is trading in line with the broader index IShares China Large-Cap ETF (NYSE:

BABA

2 minute read

Top 4 Utilities Stocks That Could Sink Your Portfolio In December

By Avi Kapoor

December 28, 9:50 AM

As of Dec. 28, 2023, three stocks in the utilities sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.

CWEN

2 minute read

Regeneron Celebrates Legal Win: Court Upholds Eylea Medication Patent

By Vandana Singh

December 28, 9:46 AM

Wednesday, a court ruling that found Viatris Inc's (NASDAQ:

REGN

2 minute read

NeuroBo Pharmaceuticals Submits IND Application To The FDA For A Phase 1 Clinical Trial Of DA-1726 For The Treatment Of Obesity

By Benzinga Newsdesk

December 28, 9:46 AM

NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that it has submitted an Investigational New Drug (IND) application to

NRBO